IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Fisher & Paykel Healthcare Ltd. v ResMed Ltd. [2016] APO 48
Patent Application: 2009221630
Title:Mask system
Patent Applicant: ResMed Ltd.
Opponent: Fisher & Paykel Healthcare Ltd.
Delegate: Dr W.E. Guinea
Decision Date: 15 July 2016
Hearing Date: 26 and 27 May 2016, in Sydney
Catchwords: PATENTS – section 59 – opposition to the grant of a patent – novelty – inventive step – manner of manufacture – fair basis – some claims found to lack inventive step – no other grounds successful – Regulation 5.23 invoked
Representation: Counsel for the Applicant: Angus Lang
Patent Attorney for the Applicant: Robynne Sanders and Louis Italiano of DLA Piper, Paul Green, Julian Magarey and Mark Abourizk of ResMed Ltd.
Counsel for the Opponent: Cameron Moore SC and Andrew Fox
Patent Attorney for the Opponent: Joe Seisdedos and Gilulia Fimmano of AJ Park, Ben Halberg of Fisher & Paykel Healthcare Ltd.
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2009221630
Title:Mask system
Patent Applicant: ResMed Ltd.
Date of Decision: 15 July 2016
DECISION
The Opposition is successful. Claims 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19 and 20 are found to lack inventive step. All other grounds of opposition were unsuccessful.
I invoke Regulation 5.23 with regard to document D4.
I allow the proposed amendments to the statement of grounds and particulars dated 8 June 2016.
The Applicant has two months from the date of this decision to propose amendments that overcome the deficiency with respect to inventive step.
No award of costs is made.
REASONS FOR DECISION
Background
1. Patent application 2009221630 (“the opposed application”) entered national phase in Australia on 31 August 2010 from PCT application PCT/AU2009/000241.
2. ResMed Ltd. (“the Applicant”) requested examination on 14 November 2012, and the opposed application was advertised as accepted on 17 July 2014.
3. A notice of opposition was filed by Fisher & Paykel Healthcare Ltd. (“the Opponent”) on 17 October 2014. The Opponent filed a statement of grounds and particulars (“original SGP”) on 19 January 2015.
4. Evidence in support (“EIS”) was filed on 17 April 2015. This comprised:
· a first statutory declaration dated 9 April 2015 by Mr Alistair Edwin McAuley (“McAuley1”) with supporting exhibits AM-1 and AM-2;
· a second statutory declaration dated 14 April 2015 by Mr Alistair Edwin McAuley (“McAuley2”);
· a third statutory declaration dated 17 April 2015 by Mr Alistair Edwin McAuley (“McAuley3”);
· a statutory declaration dated 16 April 2015 by Mr Troy Alan Baker (“Baker”) with supporting exhibit TB-1;
· a statutory declaration dated 17 April 2015 by Mr Christopher Earl Nightingale (“Nightingale”); and
· a statutory declaration dated 2 April 2015 by Professor David Maurice Rapoport (“Rapoport”) with supporting exhibit DR-1.
5. Evidence in answer (“EIA”) was filed on 17 July 2015. This comprised:
· a statutory…
Keep reading for free
Create a free CaseChat account to read Fisher & Paykel Healthcare Ltd. v ResMed Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2016] APO 48
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi